| Annual Financials | 2025 | 2026 | TTM |
Revenue  | 112 | 238 | 0 |
| Expenses | 98 | 209 | 0 |
| EBITDA | 14 | 29 | 0 |
| Operating Profit % | 9 % | 10 % | 0 % |
| Depreciation | 1 | 2 | 0 |
| Interest | 2 | 4 | 0 |
| Profit Before Tax | 11 | 24 | 0 |
| Tax | 2 | 5 | 0 |
| Net Profit | 8 | 18 | 0 |
| EPS in ₹ | 7.70 | 15.39 | 0.00 |
Hemant Surgical Industries
Hemant Surgical Industries
618.90
+5.35
(0.87%)
Market Cap
899.78 Cr
PE Ratio
49.04
Volume
9,600.00
Day High - Low
620.00 - 600.00
52W High-Low
629.75 - 215.00
Key Fundamentals
Market Cap
899.78 Cr
EPS
15.39
PE Ratio
49.04
PB Ratio
5.69
Book Value
107.89
EBITDA
29.10
Dividend Yield
0.00 %
Industry
Healthcare Sector
Medical Equipment Return on Equity
13.22
Debt to Equity
0.40
Actual
Company News
View All News
Hemant Surgical approves FY26 Directors' Report
Aug 29, 2026
Aug 29, 2026Hemant Surgical Industries approved its Directors' Report for FY26 and scheduled its 37th AGM for September 29, 2026, via video conference.
Hemant Surgical revises SKD pact termsJun 09, 2026
Jun 09, 2026Hemant Surgical Industries revised its Semi Knocked Down manufacturing agreement with Sonomed Escalon, USA. The agreement covers A-scan and pachymetry devices for the Indian market.
Hemant Surgical Industries Limited acquired a 66.66% stake in Lifesenz Cancer Research Labs for ₹19.98 Crores. The acquisition strengthens its healthcare portfolio and entry into precision oncology.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,724.40 | #1 17,478.43 | 55.54 | #1 1,995.30 | 13.43 | #1 321 | -8.38 | 50.05 | |
332.75 | 1,770.44 | 160.48 | 446.70 | 9.38 | 14 | -177.78 | 54.16 | |
668.45 | 1,559.37 | 28.25 | 341.74 | 5.93 | 56 | #1 314.63 | 55.93 | |
199.07 | 1,094.13 | 35.01 | 286.40 | 18.15 | 26 | 24.10 | 49.43 | |
618.90 | #5 899.78 | #7 49.04 | #8 237.70 | #1 112.99 | #7 18 | - | 79.16 | |
414.00 | 718.02 | 63.48 | 278.87 | 10.97 | 10 | 51.85 | 55.00 | |
385.90 | 686.69 | 23.80 | 294.60 | 57.88 | 29 | - | 51.41 | |
145.83 | 648.23 | #1 13.37 | 410.77 | 22.29 | 36 | 168.85 | 43.18 | |
380.00 | 456.16 | 20.94 | 76.70 | 14.31 | 21 | 27.27 | 46.65 | |
196.64 | 380.25 | 29.58 | 173.90 | 10.27 | 12 | 25.00 | 80.32 |
Growth Rate
Revenue Growth
112.99 %
Net Income Growth
127.50 %
Cash Flow Change
-792.01 %
ROE
3.85 %
ROCE
34.16 %
EBITDA Margin (Avg.)
-3.09 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2025 | 2026 |
| Total Assets | 148 | 274 |
| Fixed Assets | 40 | 53 |
| Current Assets | 89 | 192 |
| Capital Work in Progress | 12 | 0 |
| Investments | 0 | 0 |
| Other Assets | 97 | 221 |
| Total Equity & Liabilities | 148 | 274 |
| Current Liabilities | 61 | 133 |
| Non Current Liabilities | 24 | 4 |
| Total Equity | 63 | 138 |
| Reserve & Surplus | 53 | 114 |
| Share Capital | 10 | 13 |
Cash Flow
| Cash Flow | 2025 | 2026 |
| Net Cash Flow | -4 | 34 |
| Investing Activities | -30 | -3 |
| Operating Activities | 5 | -32 |
| Financing Activities | 22 | 69 |
Share Holding
| % Holding | Jun 2023 | Sept 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Mar 2026 | May 2026 |
| Promoter | 73.56 % | 73.56 % | 73.56 % | 73.56 % | 73.56 % | 58.90 % | 58.90 % | 52.83 % | 52.83 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.39 % | 0.15 % | 0.15 % | 0.14 % | 0.14 % |
| DIIs | 0.49 % | 0.00 % | 1.97 % | 1.13 % | 1.11 % | 10.81 % | 10.81 % | 9.62 % | 19.94 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 11.00 % | 17.47 % | 20.64 % | 20.24 % | 20.87 % | 23.17 % | 23.22 % | 22.61 % | 22.61 % |
| Others | 14.94 % | 8.97 % | 3.82 % | 5.07 % | 4.06 % | 6.97 % | 6.91 % | 14.80 % | 4.49 % |
| No of Share Holders | 830 | 722 | 1,229 | 1,248 | 1,229 | 748 | 758 | 948 | 948 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 29 Sept 2026 |  Annual General Meeting | NA | 29 Sept 2026 | 370.95 | 616.20 |
| 25 Sept 2024 | Annual General Meeting | NA | 25 Sept 2024 | 160.50 | 154.50 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 147.00 | 146.55 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 106.00 | 105.00 |
| 30 Aug 2025 |  Extraordinary General Meeting | NA | 30 Aug 2025 | 234.00 | 292.00 |
| 23 Sept 2025 | Annual General Meeting | NA | 23 Sept 2025 | 290.70 | 352.65 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 290.00 | 290.00 |
| 15 May 2026 | Quarterly Result Announcement | NA | 15 May 2026 | 301.50 | 390.80 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2026
Sep 05, 2026The Company Has Issued Letters To Those ShareholderS Whose Email Addresses Are Not Registered With The Company/RTA/ Depository Participants.Sep 04, 2026
Sep 04, 2026Reg. 34 (1) Annual Report.Sep 04, 2026
Sep 04, 2026Notice Of The 37Th Annual General Meeting (AGM) Of The Company Will Be Held On Tuesday September 29 2026.Sep 04, 2026
Sep 04, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 31, 2026
Aug 31, 2026Board Meeting Outcome for Held On August 29 2026Aug 29, 2026
Aug 29, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2026
Jul 10, 2026Revised Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon USAJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Updates on AcquisitionJun 01, 2026
Jun 01, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
May 30, 2026Announcement under Regulation 30 (LODR)-AcquisitionMay 27, 2026
May 27, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 20, 2026
May 20, 2026Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011May 20, 2026
May 20, 2026Announcement under Regulation 30 (LODR)-AllotmentMay 15, 2026
May 15, 2026Intimation Of Appointment Of Cost AuditorMay 15, 2026
May 15, 2026Intimation Of Appointment Of Internal AuditorMay 15, 2026
May 15, 2026Intimation Of Appointment Of Secretarial AuditorMay 15, 2026
May 15, 2026Audited Financial Results Of The Company For Half And Financial Year Ended March 31 2026May 15, 2026
May 15, 2026Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 And 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Held On Friday May 15 2026May 15, 2026
May 15, 2026Board Meeting Intimation for Audited Standalone And Consolidated Financial Results Of The Company For The Half Year And Financial Year Ended March 31 2026May 09, 2026
May 09, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 02, 2026
Apr 02, 2026Execution Of Semi Knocked Down (SKD) Manufacturing Agreement With Sonomed Escalon USAMar 31, 2026
Mar 31, 2026Closure of Trading WindowMar 27, 2026
Mar 27, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderFeb 19, 2026
Feb 19, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Jan 12, 2026Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Nov 12, 2025Statement Of Deviation Or Variation Pursuant To Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Nov 12, 2025
Nov 12, 2025Un-Audited Financial Results Of The Company For The Half Year Ended On September 30 2025.Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Held On Wednesday November 12 2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for To Consider And Approve The Unaudited Financial Results Of The Company For Half Year Ended On September 30 2025Nov 05, 2025
Nov 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Closure of Trading WindowSep 27, 2025
Sep 27, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 23, 2025
Sep 23, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 23, 2025
Sep 23, 2025Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 22, 2025
Sep 22, 2025Announcement under Regulation 30 (LODR)-AllotmentSep 18, 2025
Sep 18, 2025Announcement under Regulation 30 (LODR)-AllotmentSep 16, 2025
Sep 16, 2025Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderSep 11, 2025
Sep 11, 2025Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 30, 2025
Aug 30, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Aug 30, 2025Dispatch Of Letter To ShareholdersAug 29, 2025
Aug 29, 2025Reg. 34 (1) Annual Report.Aug 29, 2025
Aug 29, 2025Notice Of The 36Th Annual General Meeting (AGM) Of The Company To Be Held On September 23 2025Aug 29, 2025
Aug 29, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Aug 29, 2025Intimation For 36Th Annual General Meeting Scheduled To Be Held On Tuesday September 23 2025.Aug 28, 2025
Aug 28, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateAug 28, 2025
Aug 28, 2025 Intimation Of Appointment Of Secretarial Auditor Cost Auditor And Internal Auditor.Aug 28, 2025
Aug 28, 2025Technical Indicators
RSI(14)
Neutral 78.97
ATR(14)
Less Volatile 34.87
STOCH(9,6)
Overbought 85.43
STOCH RSI(14)
Overbought 98.17
MACD(12,26)
Bullish 20.32
ADX(14)
Strong Trend 35.35
UO(9)
Bearish 80.62
ROC(12)
Uptrend And Accelerating 28.23
WillR(14)
Overbought -5.40
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
